The concept of a “Right to Try” has been spreading through the U.S. over the last four years, beginning with the first passing of such laws in Colorado in 2014. Most recently, President Trump has echoed support for a federal Right to Try law in his State of the Union address. The core concept of a “Right to Try” is that terminally ill patients should be able to access experimental therapies that have successfully completed a Phase I clinical trial but have not completed FDA Phase II and III clinical trials and received FDA approval to enter the market.
Read the full post, "National Right to Try Act Passes U.S. House" on our Life Sciences Decoded blog.